Skip to content

Prospective Study Evaluating a Novel Mobile App Based Preventive Behavioral Intervention for Perinatal Mood Disorders

Positive Intelligence - Prospective Study Evaluating a Novel Mobile App Based Preventive Behavioral Intervention for Perinatal Mood Disorders

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04914299
Enrollment
0
Registered
2021-06-04
Start date
2021-07-01
Completion date
2022-07-01
Last updated
2025-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perinatal Anxiety, Perinatal Depression

Brief summary

The primary aim of the study is to investigate whether a novel mobile App-based behavioral intervention in pregnant women can: (1) prevent and/or decrease the incidence of perinatal mood disorders (2) decrease the severity and/or duration of perinatal mood disorders in affected participants (3) increase access of pregnant women to behavioral intervention and support tools (4) increase the satisfaction of pregnant women with their prenatal care.

Detailed description

Perinatal depression is an episode of major or minor depression that occurs during pregnancy or in the 12 months after birth; it affects about 10% of new mothers. Postpartum depression accounts for 12.5% of psychologically related hospitalizations among women. In 2019, the United States Preventive Services Task Force (USPSTF) recommended screening pregnant women to identify those at risk for perinatal depression and refer them for counseling. The USPSTF recommendation is based on growing literature indicating that counseling women at risk for perinatal depression reduce the risk of having an episode of major depression by 40%. Supporting that, multiple studies have shown that cognitive-behavioral intervention and mental health care adjuvant therapy can effectively improve the condition of patients with postpartum depression. Finally, access to care has also been shown to be an important factor in determining the success of any intervention. Women across high and low-risk groups often have barriers to treatment due to stigma, shame, and fear to disclose symptoms to health providers In this research, the investigators aim to investigate whether a novel mobile App-based behavioral intervention can meaningfully increase access and demonstrate a beneficial effect in preventing anxiety and depression in the postpartum period. Furthermore and adding to the existing literature in post-partum depression, this study aims to investigate the role of positive intelligence, an integrative positive cognitive behavioral therapy, as a tool in the prevention and treatment of perinatal mood disorders.

Interventions

BEHAVIORALApp-based positive intelligence intervention

A 6 weeks App-guided and support-group based positive intelligence cognitive behavioral intervention in addition to standard prenatal and postnatal care

BEHAVIORALStandard of care

Standard prenatal and postnatal care(Providing psychoeducation and referral to psychotherapy or pharmacotherapy based on participant's symptoms).

Sponsors

Positive Intelligence Inc.
CollaboratorUNKNOWN
Massachusetts General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

Two groups: One receives a novel mobile-App based intervention and the other groups receives standard of care (psychoeducation about postpartum depression, referral and monitoring).

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Able to read and speak English * Have a low-risk singleton pregnancy with more than 24 weeks of gestation * Have smartphone with internet access * Failure to meet criteria for a diagnosis of MDD in the last two months

Exclusion criteria

* Physical or mental disorders which would interfere with their ability to participate in the study * High-risk pregnancy * Give birth to a newborn at still-birth or a newborn with congenital anomalies and/or Medical complications that require special care in hospital * Infant has a birth weight lower than 2,500 grams * Infant has a 5-minute Apgar score lower than 7

Design outcomes

Primary

MeasureTime frameDescription
Postpartum Depression Symptoms3rd trimester pregnancy till 6 months postpartumPostpartum Depression Symptoms measured by Edinburgh Postnatal Depression Scale postpartum. Scale 1-30,with 0 indicating no symptoms, and 30 indicating the highest severity of symptoms.

Secondary

MeasureTime frameDescription
Completion of App-based intervention program6 weeks postpartumSelf reported completion of App based 6 weeks training program.
Patient Satisfaction6 weeks postpartum to 6 months postpartumPatient satisfaction measured by Client Satisfaction Questionnaire scale. scale 8-32, with higher scores indicate greater satisfaction.
Generalized Anxiety Symptoms3rd trimester pregnancy till 6 months postpartumAnxiety Symptoms measured by Generalized Anxiety Scale. scale 0-21, with with 0 indicating no symptoms, and 21 indicating the highest severity of symptoms.
Patient depression symptoms and severity3rd trimester pregnancy till 6 months postpartumDepression Symptoms measured by Patient Health Questionnaire scale. Scale 0-27, with 0 indicating no symptoms, and 27 indicating the highest severity of symptoms.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026